ChemInform Abstract: Substituted Imidazoles a Glucagon Receptor Antagonists.

ChemInform ◽  
2010 ◽  
Vol 33 (5) ◽  
pp. no-no
Author(s):  
Linda L. Chang ◽  
et al. et al.
Author(s):  
Chang‐Yong Lee ◽  
Hojung Choi ◽  
Eun‐Young Park ◽  
Thi‐Thao‐Linh Nguyen ◽  
Han‐Joo Maeng ◽  
...  

Physiology ◽  
2005 ◽  
Vol 20 (5) ◽  
pp. 357-365 ◽  
Author(s):  
Elaine M Sinclair ◽  
Daniel J. Drucker

Glucagon is used for the treatment of hypoglycemia, and glucagon receptor antagonists are under development for the treatment of type 2 diabetes. Moreover, glucagon-like peptide (GLP)-1 and GLP-2 receptor agonists appear to be promising therapies for the treatment of type 2 diabetes and intestinal disorders, respectively. This review discusses the physiological, pharmacological, and therapeutic actions of the proglucagon-derived peptides, with an emphasis on clinical relevance of the peptides for the treatment of human disease.


2011 ◽  
Vol 21 (1) ◽  
pp. 76-81 ◽  
Author(s):  
Dong-Ming Shen ◽  
Edward J. Brady ◽  
Mari R. Candelore ◽  
Qing Dallas-Yang ◽  
Victor D.-H. Ding ◽  
...  

2006 ◽  
Vol 14 (5) ◽  
pp. 1506-1517 ◽  
Author(s):  
Sheila M. Cohen ◽  
Joseph L. Duffy ◽  
Corin Miller ◽  
Brian A. Kirk ◽  
Mari Rios Candelore ◽  
...  

2005 ◽  
Vol 15 (20) ◽  
pp. 4564-4569 ◽  
Author(s):  
Dong-Ming Shen ◽  
Fengqi Zhang ◽  
Edward J. Brady ◽  
Mari Rios Candelore ◽  
Qing Dallas-Yang ◽  
...  

1999 ◽  
Vol 9 (5) ◽  
pp. 641-646 ◽  
Author(s):  
Stephen E. de Laszlo ◽  
Candice Hacker ◽  
Bing Li ◽  
Dooseop Kim ◽  
Malcolm MacCoss ◽  
...  

2009 ◽  
Vol 52 (9) ◽  
pp. 2989-3000 ◽  
Author(s):  
Peter Madsen ◽  
János T. Kodra ◽  
Carsten Behrens ◽  
Erica Nishimura ◽  
Claus B. Jeppesen ◽  
...  

2018 ◽  
Vol 92 (1) ◽  
pp. 1241-1254
Author(s):  
Jia Li ◽  
Yang Feng ◽  
Huihui Li ◽  
Shuangjie Shu ◽  
Antao Dai ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document